---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-000622"
form_type: "8-K"
ticker: "PBYI"
cik: "0001401667"
company_name: "PUMA BIOTECHNOLOGY, INC."
filed_at: "2022-01-10T23:59:59+00:00"
generated_at: "2026-06-27T19:18:05.068533+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "low"
source: SEC EDGAR
---

# Puma Biotechnology CEO to present at investor conferences beginning Jan 10, 2022

## Summary
- CEO Alan Auerbach will present at conferences and other forums starting January 10, 2022.
- Presentation slides attached as Exhibit 99.1 contain the information to be disclosed.
- No specific financial or operational details from the slides are available in this filing text.

## SEC filing metadata
- accession: 0001437749-22-000622
- form_type: 8-K
- ticker: PBYI
- cik: 0001401667
- company_name: PUMA BIOTECHNOLOGY, INC.
- filed_at: 2022-01-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401667/000143774922000622/0001437749-22-000622-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401667/000143774922000622/pbyi20220106_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-000622
- JSON: https://secwatch.observer/filing/0001437749-22-000622.json
- Plain text: https://secwatch.observer/filing/0001437749-22-000622.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.